Alendronate and osteoporosis
- 28 February 1998
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 3 (2), 69-78
- https://doi.org/10.1016/s1359-6446(97)01134-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tiludronate inhibits protein tyrosine phosphatase activity in osteoclastsBone, 1997
- Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino groupJournal of Bone and Mineral Research, 1996
- Bisphosphonates: mechanisms of action.JCI Insight, 1996
- Bisphosphonates: A review of their pharmacokinetic propertiesBone, 1996
- Effects of sodium fluoride and alendronate on the bone mineral in minipigs: A small-angle X-ray scattering and backscattered electron imaging studyJournal of Bone and Mineral Research, 1996
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.JCI Insight, 1995
- The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.JCI Insight, 1993
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.JCI Insight, 1991
- The long-term skeletal effects of EHDP in dogsMetabolic Bone Disease and Related Research, 1981